sage therapeutics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies market research report sage therapeutics inc  product pipeline review   published by global markets direct product code  published august   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license sage therapeutics inc  product pipeline review   published august   content info  pages description summary global markets directs sage therapeutics inc  product pipeline review   provides an overview of the sage therapeutics incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by sage therapeutics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope the report provides a snapshot of the pipeline therapeutic landscape of sage therapeutics inc the report provides overview of sage therapeutics inc including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses sage therapeutics incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features sage therapeutics incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy evaluate sage therapeutics incs strategic position with total access to detailed information on its product pipeline gain strategically significant competitor information analysis and insights to formulate effective rd strategies identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage identify and understand important and diverse types of therapeutics under development for sage therapeutics inc identify potential new clients or partners in the target demographic plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics devise corrective measures for pipeline projects by understanding sage therapeutics incs pipeline depth and focus of pipeline therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures sage therapeutics inc snapshot sage therapeutics inc overview key information key facts sage therapeutics inc  research and development overview key therapeutic areas sage therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy sage therapeutics inc  pipeline products glance sage therapeutics inc  late stage pipeline products phase iii productscombination treatment modalities sage therapeutics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities sage therapeutics inc  early stage pipeline products indcta filed productscombination treatment modalities preclinical productscombination treatment modalities discovery productscombination treatment modalities sage therapeutics inc  drug profiles sepranolone product description mechanism of action rd progress sage product description mechanism of action rd progress sage product description mechanism of action rd progress sage product description mechanism of action rd progress sage product description mechanism of action rd progress sage product description mechanism of action rd progress sge product description mechanism of action rd progress small molecules to agonize nmda receptor for cognitive disorders product description mechanism of action rd progress small molecules to agonize nmda receptor for cns disorders product description mechanism of action rd progress small molecules to modulate gabaa receptor for cns disorders product description mechanism of action rd progress sage therapeutics inc  pipeline analysis sage therapeutics inc  pipeline products by target sage therapeutics inc  pipeline products by route of administration sage therapeutics inc  pipeline products by molecule type sage therapeutics inc  pipeline products by mechanism of action sage therapeutics inc  recent pipeline updates sage therapeutics inc  dormant projects sage therapeutics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables sage therapeutics inc key information sage therapeutics inc key facts sage therapeutics inc  pipeline by indication  sage therapeutics inc  pipeline by stage of development  sage therapeutics inc  monotherapy products in pipeline  sage therapeutics inc  phase iii  sage therapeutics inc  phase ii  sage therapeutics inc  phase i  sage therapeutics inc  indcta filed  sage therapeutics inc  preclinical  sage therapeutics inc  discovery  sage therapeutics inc  pipeline by target  sage therapeutics inc  pipeline by route of administration  sage therapeutics inc  pipeline by molecule type  sage therapeutics inc  pipeline products by mechanism of action  sage therapeutics inc  recent pipeline updates  sage therapeutics inc  dormant developmental projects list of figures sage therapeutics inc  pipeline by top  indication  sage therapeutics inc  pipeline by stage of development  sage therapeutics inc  monotherapy products in pipeline  sage therapeutics inc  pipeline by target  sage therapeutics inc  pipeline by route of administration  sage therapeutics inc  pipeline by molecule type  sage therapeutics inc  pipeline products by mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved stockscountryunited states index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pstitch fix has confidentially filed to go public report pcan china make the reflation trade great again pget ready for the lessprofitable amazon that you used to know pmattel stock price target cut to  from  at mkm partners pelectronic arts stock price target raised to  from  at mkm partners pexxon mobil stock price target cut to  from  at cfra pthe states where people spend the most on lotto tickets ptempur sealy stock price target raised to  from  at cfra pfiat chrysler gets approval to sell diesel cars pstarbucks’ teavana stores are the latest casualty at the mall phigh times is going public through a deal with a blankcheck company — and here’s what that means pintel earnings have message for amd and nvidia ‘bring it on’ pfoxconn’s history of broken promises casts a shadow on wisconsin news ptesla’s model  will be launched with panacheand a partylater friday pall the companies in jeff bezos’s empire in one large chart pbaker hughes data show weekly us oilrig count up a third time this month pamazon’s postearnings stock selloff is the smallest in seven years peuropean stocks end at month low as ubs falls tech worries weigh psurging australian dollar makes life tough for central bankers pseptember wti oil trades at bbl little changed from before the rig data loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pstitch fix has confidentially filed to go public report pcan china make the reflation trade great again pget ready for the lessprofitable amazon that you used to know pmattel stock price target cut to  from  at mkm partners pelectronic arts stock price target raised to  from  at mkm partners pexxon mobil stock price target cut to  from  at cfra pthe states where people spend the most on lotto tickets ptempur sealy stock price target raised to  from  at cfra pfiat chrysler gets approval to sell diesel cars pstarbucks’ teavana stores are the latest casualty at the mall phigh times is going public through a deal with a blankcheck company — and here’s what that means pintel earnings have message for amd and nvidia ‘bring it on’ pfoxconn’s history of broken promises casts a shadow on wisconsin news ptesla’s model  will be launched with panacheand a partylater friday pall the companies in jeff bezos’s empire in one large chart pbaker hughes data show weekly us oilrig count up a third time this month pamazon’s postearnings stock selloff is the smallest in seven years peuropean stocks end at month low as ubs falls tech worries weigh psurging australian dollar makes life tough for central bankers pseptember wti oil trades at bbl little changed from before the rig data loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pstitch fix has confidentially filed to go public report pcan china make the reflation trade great again pget ready for the lessprofitable amazon that you used to know pmattel stock price target cut to  from  at mkm partners pelectronic arts stock price target raised to  from  at mkm partners pexxon mobil stock price target cut to  from  at cfra pthe states where people spend the most on lotto tickets ptempur sealy stock price target raised to  from  at cfra pfiat chrysler gets approval to sell diesel cars pstarbucks’ teavana stores are the latest casualty at the mall phigh times is going public through a deal with a blankcheck company — and here’s what that means pintel earnings have message for amd and nvidia ‘bring it on’ pfoxconn’s history of broken promises casts a shadow on wisconsin news ptesla’s model  will be launched with panacheand a partylater friday pall the companies in jeff bezos’s empire in one large chart pbaker hughes data show weekly us oilrig count up a third time this month pamazon’s postearnings stock selloff is the smallest in seven years peuropean stocks end at month low as ubs falls tech worries weigh psurging australian dollar makes life tough for central bankers pseptember wti oil trades at bbl little changed from before the rig data loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » sage stock price  sage therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  expe  col  fls  gt  sbux  mo  latest newsall times eastern p stitch fix has confidentially filed to go public report p can china make the reflation trade great again p updated get ready for the lessprofitable amazon that you used to know p mattel stock price target cut to  from  at mkm partners p electronic arts stock price target raised to  from  at mkm partners p exxon mobil stock price target cut to  from  at cfra p updated the states where people spend the most on lotto tickets p tempur sealy stock price target raised to  from  at cfra p fiat chrysler gets approval to sell diesel cars p updated starbucks’ teavana stores are the latest casualty at the mall to be replaced home investing quotes stocks united states sage overview compare quotes stock screener earnings calendar sectors nasdaq sage us nasdaq join td ameritrade find a broker sage therapeutics inc watchlist createsagealert open last updated jul    pm edt real time quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones nasdaq composite ventures under the day average retest underway us stocks are lower early thursday pressured against the backdrop of a headline technical test specifically the nasdaq composite is back for its latest crack at the day moving average — currently  — an area that initially underpinned the earlyweek downdraft as a widelytracked intermediateterm trending indicator this area marks a bullbear inflection point jun   at  am et by michael ashbaugh sp  dow nail the trendline pull in from resistance apr   at  pm et by michael ashbaugh us stocks open lower indexes remain near record levels mar   at  am et by ryan vlastelica sage jumps  on expedited development plan for postpartum depression treatment dec   at  am et by emma court sage rises  after announcement of expedited development plan for postpartum depression drug dec   at  am et by emma court sage therapeutics started at buy with  stock price target at stifel nicolaus nov   at  am et by tomi kilgore sage therapeutics reports positive data from phase  trial of postpartum depression drug sep   at  am et by ciara linnane sage therapeutics started at outperform with  stock price target at raymond james sep   at  am et by tomi kilgore sage therapeutics stock rises  after fda designates drug a breakthrough therapy sep   at  pm et by emma court sage therapeutics stock rises  after fda designates drug a breakthrough therapy sep   at  pm et by emma court dow sp  close at record highs jul   at  pm et by ellie ismailidou why gold and biotechs will be the next to fly after the sp’s recordbuster jul   at  am et by barbara kollmeyer sage therapeutics shares surge  on positive trail of postpartum depression drug jul   at  am et by ciara linnane opinion almost half of venturebacked ipos this year are losers oct   at  am et by philip van doorn google rises on earnings amd sinks to fourmonth low jul   at  pm et by sue chang breaking sage therapeutics soars more than  on debut jul   at  am et by sue chang breaking sage therapeutics soars  on market debut jul   at  am et by sue chang no headlines available recent news other news press releases q biotech catalyst watch phase  data releases part  q biotech catalyst watch phase  data releases part  jul   at  am et on seeking alpha sage therapeutics spicing up portfolios sage therapeutics spicing up portfolios jul   at  am et on seeking alpha sage therapeutics brexanolone shows treatment effect in midstage ppd study sage therapeutics brexanolone shows treatment effect in midstage ppd study jun   at  am et on seeking alpha whats next for sage therapeutics whats next for sage therapeutics may   at  am et on seeking alpha  biotech stocks with improving fundamentals  biotech stocks with improving fundamentals may   at  pm et on seeking alpha an experts view on new cns drugs including esketamine sage and sage in ppd and mdd an experts view on new cns drugs including esketamine sage and sage in ppd and mdd may   at  pm et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare may   at  am et on seeking alpha commentary on great point partners positions part  commentary on great point partners positions part  may   at  am et on seeking alpha sage therapeutics sage ceo jeff jonas on q  results  earnings call transcript sage therapeutics sage ceo jeff jonas on q  results  earnings call transcript may   at  pm et on seeking alpha sage therapeutics  q  results  earnings call slides sage therapeutics  q  results  earnings call slides may   at  pm et on seeking alpha fernwood investment management llc buys global blood therapeutics inc ubiquiti networks inc  fernwood investment management llc buys global blood therapeutics inc ubiquiti networks inc texas pacific land trust sells broadcom energy transfer partners lp energy transfer partners lp may   at  pm et on gurufocuscom marinus pharmaceuticals a discarded cns gem ready to shine in  marinus pharmaceuticals a discarded cns gem ready to shine in  may   at  pm et on seeking alpha biotech bonanza  approaching an inflection point biotech bonanza  approaching an inflection point may   at  am et on seeking alpha vcbacked ipos in private biotech murky with many shades of black vcbacked ipos in private biotech murky with many shades of black may   at  pm et on seeking alpha buy bank of america  cramers lightning round  apr   at  am et on seeking alpha hershey trust co buys momo vipshop holdings ametek sells sage therapeutics jd  apr   at  pm et on gurufocuscom biotech forum daily digest neurocrines big win spotlight on idera pharmaceuticals apr   at  pm et on seeking alpha trump trade is redefined  cramers mad money  apr   at  am et on seeking alpha  drug stocks for your portfolio this world health day apr   at  am et on zackscom are options traders betting on a big move in sage therapeutics sage stock mar   at  am et on zackscom sage therapeutics to report second quarter  financial results on thursday august   sage therapeutics to report second quarter  financial results on thursday august   jul   at  pm et on businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c sage therapeutics announces inducement grants under nasdaq listing rule c jul   at  pm et on businesswire  bzx sage therapeutics announces the lancet publishes positive phase  brexanolone sage clinical data in severe postpartum depression sage therapeutics announces the lancet publishes positive phase  brexanolone sage clinical data in severe postpartum depression jun   at  pm et on businesswire  bzx sage therapeutics to present at goldman sachs healthcare conference sage therapeutics to present at goldman sachs healthcare conference jun   at  pm et on businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c sage therapeutics announces inducement grants under nasdaq listing rule c jun   at  am et on businesswire  bzx sage therapeutics receives fast track designation for sage for the treatment of major depressive disorder sage therapeutics receives fast track designation for sage for the treatment of major depressive disorder may   at  am et on businesswire  bzx sage therapeutics announces first quarter  financial results and provides pipeline update sage therapeutics announces first quarter  financial results and provides pipeline update may   at  pm et on businesswire  bzx investor network sage therapeutics inc to host earnings call investor network sage therapeutics inc to host earnings call may   at  pm et on accesswire sage therapeutics announces inducement grants under nasdaq listing rule c sage therapeutics announces inducement grants under nasdaq listing rule c may   at  pm et on businesswire  bzx sage therapeutics announces initiation of phase  development and first dosing of sage apr   at  am et on businesswire  bzx how these biotech stocks are faring  cymabay therapeutics benitec biopharma sage therapeutics and catalyst biosciences apr   at  am et on pr newswire  prf sage therapeutics to report first quarter  financial results on tuesday may   apr   at  pm et on businesswire  bzx sage therapeutics appoints michael cloonan as chief business officer and expands executive team apr   at  am et on businesswire  bzx sage therapeutics to present at american academy of neurology  annual meeting apr   at  am et on businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c apr   at  pm et on businesswire  bzx pershing gold to present at  european gold forum apr   at  am et on pr newswire  prf biotech stocks under scanner  biodelivery sciences sage therapeutics benitec biopharma and oncogenex pharma mar   at  am et on pr newswire  prf option trades covered call reports for american airlines alnylam pharmaceuticals the kroger co resolute energy corporation and sage therapeutics include trade ideas that offer returns of  or more mar   at  am et on pr newswire  prf sage therapeutics announces inducement grants under nasdaq listing rule c mar   at  pm et on businesswire  bzx blog coverage la jollas lead product candidate ljpc posts positive phaseiii trial results feb   at  am et on accesswire benzingas top upgrades downgrades for may   may   at  am et on benzingacom benzingas top initiations oct   at  am et on benzingacom benzingas top initiations jun   at  am et on benzingacom competitors name chg  market cap regulus therapeutics inc  m intercept pharmaceuticals inc  b eagle pharmaceuticals inc  m horizon pharma plc  b competitor data provided by partner content trending tickers powered by sbux  dvax  aks  bidu  x  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience sage therapeutics inc  product pipeline review    now available at market reports center infomarketreportscentercom  us x login sign up facebook twitter linkedin google  mrc blog youtube sage therapeutics inc  product pipeline review   home   global markets direct  sage therapeutics inc  product pipeline review   report details sage therapeutics inc  product pipeline review   sku gmdsep category publisher global markets direct pages  published aug skugmdsep category publisherglobal markets direct pages published onaug request discount pay by wireinvoice description table of content list of figures request sample description sage therapeutics inc  product pipeline review   summary global markets directs sage therapeutics inc  product pipeline review   provides an overview of the sage therapeutics incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by sage therapeutics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of sage therapeutics inc  the report provides overview of sage therapeutics inc including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses sage therapeutics incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features sage therapeutics incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate sage therapeutics incs strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for sage therapeutics inc  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding sage therapeutics incs pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope newspress release table of content table of contents table of contents  list of tables  list of figures  sage therapeutics inc snapshot  sage therapeutics inc overview  key information  key facts  sage therapeutics inc  research and development overview  key therapeutic areas  sage therapeutics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  sage therapeutics inc  pipeline products glance  sage therapeutics inc  late stage pipeline products  phase iii productscombination treatment modalities  sage therapeutics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  sage therapeutics inc  early stage pipeline products  indcta filed productscombination treatment modalities  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  sage therapeutics inc  drug profiles  sepranolone  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sge  product description  mechanism of action  rd progress  small molecules to agonize nmda receptor for cognitive disorders  product description  mechanism of action  rd progress  small molecules to agonize nmda receptor for cns disorders  product description  mechanism of action  rd progress  small molecules to modulate gabaa receptor for cns disorders  product description  mechanism of action  rd progress  sage therapeutics inc  pipeline analysis  sage therapeutics inc  pipeline products by target  sage therapeutics inc  pipeline products by route of administration  sage therapeutics inc  pipeline products by molecule type  sage therapeutics inc  pipeline products by mechanism of action  sage therapeutics inc  recent pipeline updates  sage therapeutics inc  dormant projects  sage therapeutics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of figures list of tables sage therapeutics inc key information  sage therapeutics inc key facts  sage therapeutics inc  pipeline by indication   sage therapeutics inc  pipeline by stage of development   sage therapeutics inc  monotherapy products in pipeline   sage therapeutics inc  phase iii   sage therapeutics inc  phase ii   sage therapeutics inc  phase i   sage therapeutics inc  indcta filed   sage therapeutics inc  preclinical   sage therapeutics inc  discovery   sage therapeutics inc  pipeline by target   sage therapeutics inc  pipeline by route of administration   sage therapeutics inc  pipeline by molecule type   sage therapeutics inc  pipeline products by mechanism of action   sage therapeutics inc  recent pipeline updates   sage therapeutics inc  dormant developmental projects  list of figures sage therapeutics inc  pipeline by top  indication   sage therapeutics inc  pipeline by stage of development   sage therapeutics inc  monotherapy products in pipeline   sage therapeutics inc  pipeline by target   sage therapeutics inc  pipeline by route of administration   sage therapeutics inc  pipeline by molecule type   sage therapeutics inc  pipeline products by mechanism of action   please select license type single user electronic pdf   site user electronic pdf   enterprise wide electronic pdf   add to cart buy now related reports global incoloy alloy ma  sales market report  global zinc dimethyldithiocarbamate market research report  global grate bars for refuse incinerators industry report  global and chinese zinc trifluoromethanesulphonate cas  industry  market research report global and chinese zinc fumarate cas  industry  market research report request sample mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send request discount mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send pay by wireinvoice mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  single user electronic pdf site user electronic pdf enterprise wide electronic pdf cd rom hard copy send request quote mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send market reports center  copyright  all rights reserved microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft sage therapeutics inc sageo company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile sage therapeutics inc sageo related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse sageo on consolidated issue listed on nasdaq global market usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description sage therapeutics inc incorporated on april   is a clinicalstage biopharmaceutical company the company is engaged in developing and commercializing medicines to treat central nervous system cns disorders the companys lead product candidate sage is an intravenous formulation of allopregnanolone a neurosteroid that acts as a synaptic and extrasynaptic modulator of the gammaamino butyric acida gabaa receptor the companys nextgeneration product candidates sage and sage also target the gabaa receptor system the company is focused on developing drugs based on selective allosteric modulation of cns synaptic and extrasynaptic receptors the companys chemistry platform is focused on chemical scaffolds of endogenous or chemically modified synthetic neuroactive steroid compounds that are allosteric modulators of gabaa or nmethyldaspartic acid or nmethyldaspartate nmda receptorssagethe companys sage is an intravenous iv formulation of allopregnanolone which is a neurosteroid that acts as a synaptic and extrasynaptic modulator of the gabaa receptor sage is being developed as an adjunctive therapy in conjunction with underlying anesthesia as a treatment for superrefractory status epilepticus srse the company is conducting sage treatment as adjunctive therapy utilized in status epilepticus status phase iii trialssagethe companys product sage is a neuroactive steroid that is a positive allosteric modulator of gabaa receptors sage targets synaptic and extrasynaptic gabaa receptors the company is conducting phase i clinical trials sage is being studied as an oral solution the company in the process of developing a solid dosage formulation of sage intended for chronic usesagethe companys sage is a positive allosteric modulator of gabaa receptors sage has shown anticonvulsant anxiolytic and sedative properties in animal models the characteristics of sage include a therapeutic window to allow for modulation of the gabaa receptor without inducing deep anesthesia and a short halflife to permit onset and loss of activitysagethe companys sage is a product candidate selected for development from its nmda receptor program sage is an oxysterolbased positive allosteric modulator of nmda receptors sage has been designed to be a potent and selective modulator of nmda receptors with an optimized pharmacokinetic profile intended to support oral dosing the company has begun nonclinical studies of sage with an initial development focus on two conditions smithlemliopitz syndrome slos and antinmda receptor encephalitis anre slos is a metabolic disorder caused by a mutation in the dehydrocholesterol reductase dhcr gene which codes for an enzyme that is involved in the production of cholesterol in the brain anre is an autoimmune disorder in which antibodies attack nmda receptors symptoms of anre include a set of neuropsychiatric deficits including cognitive and behavioral disturbances movement disorders and loss of consciousnessthe company competes with marinus pharmaceuticals inc » full overview of sageo company address sage therapeutics inc  st stcambridge   ma    p f  company web links home page officers  directors name compensation kevin starr  jeffrey jonas  kimi iguchi  anne cook  amy schacterle  » more officers  directors sage therapeutics inc news briefsage therapeutics qtrly loss per share  may   briefsage therapeutics initiates phase  single ascending dose trial apr   briefsage therapeutics posts q loss per share of  feb   briefsage therapeutics ceo comments did not imply that co is in ma discussions feb   briefsage therapeutics advances sage feb   » more sageo news related topics stocksstock screenerhealthcarebiotechnology  medical research sage stock price  sage therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  expe  col  fls  gt  sbux  mo  latest newsall times eastern p stitch fix has confidentially filed to go public report p can china make the reflation trade great again p updated get ready for the lessprofitable amazon that you used to know p mattel stock price target cut to  from  at mkm partners p electronic arts stock price target raised to  from  at mkm partners p exxon mobil stock price target cut to  from  at cfra p updated the states where people spend the most on lotto tickets p tempur sealy stock price target raised to  from  at cfra p fiat chrysler gets approval to sell diesel cars p updated starbucks’ teavana stores are the latest casualty at the mall to be replaced home investing quotes stocks united states sage overview compare quotes stock screener earnings calendar sectors nasdaq sage us nasdaq join td ameritrade find a broker sage therapeutics inc watchlist createsagealert open last updated jul    pm edt real time quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones nasdaq composite ventures under the day average retest underway us stocks are lower early thursday pressured against the backdrop of a headline technical test specifically the nasdaq composite is back for its latest crack at the day moving average — currently  — an area that initially underpinned the earlyweek downdraft as a widelytracked intermediateterm trending indicator this area marks a bullbear inflection point jun   at  am et by michael ashbaugh sp  dow nail the trendline pull in from resistance apr   at  pm et by michael ashbaugh us stocks open lower indexes remain near record levels mar   at  am et by ryan vlastelica sage jumps  on expedited development plan for postpartum depression treatment dec   at  am et by emma court sage rises  after announcement of expedited development plan for postpartum depression drug dec   at  am et by emma court sage therapeutics started at buy with  stock price target at stifel nicolaus nov   at  am et by tomi kilgore sage therapeutics reports positive data from phase  trial of postpartum depression drug sep   at  am et by ciara linnane sage therapeutics started at outperform with  stock price target at raymond james sep   at  am et by tomi kilgore sage therapeutics stock rises  after fda designates drug a breakthrough therapy sep   at  pm et by emma court sage therapeutics stock rises  after fda designates drug a breakthrough therapy sep   at  pm et by emma court dow sp  close at record highs jul   at  pm et by ellie ismailidou why gold and biotechs will be the next to fly after the sp’s recordbuster jul   at  am et by barbara kollmeyer sage therapeutics shares surge  on positive trail of postpartum depression drug jul   at  am et by ciara linnane opinion almost half of venturebacked ipos this year are losers oct   at  am et by philip van doorn google rises on earnings amd sinks to fourmonth low jul   at  pm et by sue chang breaking sage therapeutics soars more than  on debut jul   at  am et by sue chang breaking sage therapeutics soars  on market debut jul   at  am et by sue chang no headlines available recent news other news press releases q biotech catalyst watch phase  data releases part  q biotech catalyst watch phase  data releases part  jul   at  am et on seeking alpha sage therapeutics spicing up portfolios sage therapeutics spicing up portfolios jul   at  am et on seeking alpha sage therapeutics brexanolone shows treatment effect in midstage ppd study sage therapeutics brexanolone shows treatment effect in midstage ppd study jun   at  am et on seeking alpha whats next for sage therapeutics whats next for sage therapeutics may   at  am et on seeking alpha  biotech stocks with improving fundamentals  biotech stocks with improving fundamentals may   at  pm et on seeking alpha an experts view on new cns drugs including esketamine sage and sage in ppd and mdd an experts view on new cns drugs including esketamine sage and sage in ppd and mdd may   at  pm et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare may   at  am et on seeking alpha commentary on great point partners positions part  commentary on great point partners positions part  may   at  am et on seeking alpha sage therapeutics sage ceo jeff jonas on q  results  earnings call transcript sage therapeutics sage ceo jeff jonas on q  results  earnings call transcript may   at  pm et on seeking alpha sage therapeutics  q  results  earnings call slides sage therapeutics  q  results  earnings call slides may   at  pm et on seeking alpha fernwood investment management llc buys global blood therapeutics inc ubiquiti networks inc  fernwood investment management llc buys global blood therapeutics inc ubiquiti networks inc texas pacific land trust sells broadcom energy transfer partners lp energy transfer partners lp may   at  pm et on gurufocuscom marinus pharmaceuticals a discarded cns gem ready to shine in  marinus pharmaceuticals a discarded cns gem ready to shine in  may   at  pm et on seeking alpha biotech bonanza  approaching an inflection point biotech bonanza  approaching an inflection point may   at  am et on seeking alpha vcbacked ipos in private biotech murky with many shades of black vcbacked ipos in private biotech murky with many shades of black may   at  pm et on seeking alpha buy bank of america  cramers lightning round  apr   at  am et on seeking alpha hershey trust co buys momo vipshop holdings ametek sells sage therapeutics jd  apr   at  pm et on gurufocuscom biotech forum daily digest neurocrines big win spotlight on idera pharmaceuticals apr   at  pm et on seeking alpha trump trade is redefined  cramers mad money  apr   at  am et on seeking alpha  drug stocks for your portfolio this world health day apr   at  am et on zackscom are options traders betting on a big move in sage therapeutics sage stock mar   at  am et on zackscom sage therapeutics to report second quarter  financial results on thursday august   sage therapeutics to report second quarter  financial results on thursday august   jul   at  pm et on businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c sage therapeutics announces inducement grants under nasdaq listing rule c jul   at  pm et on businesswire  bzx sage therapeutics announces the lancet publishes positive phase  brexanolone sage clinical data in severe postpartum depression sage therapeutics announces the lancet publishes positive phase  brexanolone sage clinical data in severe postpartum depression jun   at  pm et on businesswire  bzx sage therapeutics to present at goldman sachs healthcare conference sage therapeutics to present at goldman sachs healthcare conference jun   at  pm et on businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c sage therapeutics announces inducement grants under nasdaq listing rule c jun   at  am et on businesswire  bzx sage therapeutics receives fast track designation for sage for the treatment of major depressive disorder sage therapeutics receives fast track designation for sage for the treatment of major depressive disorder may   at  am et on businesswire  bzx sage therapeutics announces first quarter  financial results and provides pipeline update sage therapeutics announces first quarter  financial results and provides pipeline update may   at  pm et on businesswire  bzx investor network sage therapeutics inc to host earnings call investor network sage therapeutics inc to host earnings call may   at  pm et on accesswire sage therapeutics announces inducement grants under nasdaq listing rule c sage therapeutics announces inducement grants under nasdaq listing rule c may   at  pm et on businesswire  bzx sage therapeutics announces initiation of phase  development and first dosing of sage apr   at  am et on businesswire  bzx how these biotech stocks are faring  cymabay therapeutics benitec biopharma sage therapeutics and catalyst biosciences apr   at  am et on pr newswire  prf sage therapeutics to report first quarter  financial results on tuesday may   apr   at  pm et on businesswire  bzx sage therapeutics appoints michael cloonan as chief business officer and expands executive team apr   at  am et on businesswire  bzx sage therapeutics to present at american academy of neurology  annual meeting apr   at  am et on businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c apr   at  pm et on businesswire  bzx pershing gold to present at  european gold forum apr   at  am et on pr newswire  prf biotech stocks under scanner  biodelivery sciences sage therapeutics benitec biopharma and oncogenex pharma mar   at  am et on pr newswire  prf option trades covered call reports for american airlines alnylam pharmaceuticals the kroger co resolute energy corporation and sage therapeutics include trade ideas that offer returns of  or more mar   at  am et on pr newswire  prf sage therapeutics announces inducement grants under nasdaq listing rule c mar   at  pm et on businesswire  bzx blog coverage la jollas lead product candidate ljpc posts positive phaseiii trial results feb   at  am et on accesswire benzingas top upgrades downgrades for may   may   at  am et on benzingacom benzingas top initiations oct   at  am et on benzingacom benzingas top initiations jun   at  am et on benzingacom competitors name chg  market cap regulus therapeutics inc  m intercept pharmaceuticals inc  b eagle pharmaceuticals inc  m horizon pharma plc  b competitor data provided by partner content trending tickers powered by sbux  dvax  aks  bidu  x  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience sage key statistics  sage therapeutics inc financial ratios  marketwatch bulletin investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close sage therapeutics inc nasdaq sage go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus sage therapeutics inc market open  real time quotes jul    pm sage quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider actions – purchase – sale  – number of transactions  newslatestcompanyussage marketwatch news on sage nasdaq composite ventures under the day average retest underway  am june    michael ashbaugh sp  dow nail the trendline pull in from resistance  pm april    michael ashbaugh us stocks open lower indexes remain near record levels  am march    ryan vlastelica sage jumps  on expedited development plan for postpartum depression treatment  am dec    emma court sage rises  after announcement of expedited development plan for postpartum depression drug  am dec    emma court sage therapeutics started at buy with  stock price target at stifel nicolaus  am nov    tomi kilgore sage therapeutics reports positive data from phase  trial of postpartum depression drug  am sept    ciara linnane sage therapeutics started at outperform with  stock price target at raymond james  am sept    tomi kilgore sage therapeutics stock rises  after fda designates drug a breakthrough therapy  pm sept    emma court sage therapeutics stock rises  after fda designates drug a breakthrough therapy  pm sept    emma court dow sp  close at record highs  pm july    ellie ismailidou why gold and biotechs will be the next to fly after the sp’s recordbuster  am july    barbara kollmeyer sage therapeutics shares surge  on positive trail of postpartum depression drug  am july    ciara linnane almost half of venturebacked ipos this year are losers  am oct    philip van doorn google rises on earnings amd sinks to fourmonth low  pm july    sue chang sage therapeutics soars more than  on debut  am july    sue chang sage therapeutics soars  on market debut  am july    sue chang newsnonmarketwatchcompanyussage other news on sage q biotech catalyst watch phase  data releases part   am july    seeking alpha sage therapeutics spicing up portfolios  am july    seeking alpha sage therapeutics brexanolone shows treatment effect in midstage ppd study  am june    seeking alpha whats next for sage therapeutics  am may    seeking alpha  biotech stocks with improving fundamentals  pm may    seeking alpha an experts view on new cns drugs including esketamine sage and sage in ppd and mdd  pm may    seeking alpha premarket analyst action  healthcare  am may    seeking alpha commentary on great point partners positions part   am may    seeking alpha sage therapeutics sage ceo jeff jonas on q  results  earnings call transcript  pm may    seeking alpha sage therapeutics  q  results  earnings call slides  pm may    seeking alpha fernwood investment management llc buys global blood therapeutics inc ubiquiti networks inc   pm may    gurufocuscom marinus pharmaceuticals a discarded cns gem ready to shine in   pm may    seeking alpha biotech bonanza  approaching an inflection point  am may    seeking alpha vcbacked ipos in private biotech murky with many shades of black  pm may    seeking alpha buy bank of america  cramers lightning round   am april    seeking alpha hershey trust co buys momo vipshop holdings ametek sells sage therapeutics jd   pm april    gurufocuscom biotech forum daily digest neurocrines big win spotlight on idera pharmaceuticals  pm april    seeking alpha trump trade is redefined  cramers mad money   am april    seeking alpha  drug stocks for your portfolio this world health day  am april    zackscom are options traders betting on a big move in sage therapeutics sage stock  am march    zackscom loading more headlines newspressreleasecompanyussage press releases on sage sage therapeutics to report second quarter  financial results on thursday august    pm july    businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c  pm july    businesswire  bzx sage therapeutics announces the lancet publishes positive phase  brexanolone sage clinical data in severe postpartum depression  pm june    businesswire  bzx sage therapeutics to present at goldman sachs healthcare conference  pm june    businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c  am june    businesswire  bzx sage therapeutics receives fast track designation for sage for the treatment of major depressive disorder  am may    businesswire  bzx sage therapeutics announces first quarter  financial results and provides pipeline update  pm may    businesswire  bzx investor network sage therapeutics inc to host earnings call  pm may    accesswire sage therapeutics announces inducement grants under nasdaq listing rule c  pm may    businesswire  bzx sage therapeutics announces initiation of phase  development and first dosing of sage  am april    businesswire  bzx how these biotech stocks are faring  cymabay therapeutics benitec biopharma sage therapeutics and catalyst biosciences  am april    pr newswire  prf sage therapeutics to report first quarter  financial results on tuesday may    pm april    businesswire  bzx sage therapeutics appoints michael cloonan as chief business officer and expands executive team  am april    businesswire  bzx sage therapeutics to present at american academy of neurology  annual meeting  am april    businesswire  bzx sage therapeutics announces inducement grants under nasdaq listing rule c  pm april    businesswire  bzx pershing gold to present at  european gold forum  am april    pr newswire  prf biotech stocks under scanner  biodelivery sciences sage therapeutics benitec biopharma and oncogenex pharma  am march    pr newswire  prf option trades covered call reports for american airlines alnylam pharmaceuticals the kroger co resolute energy corporation and sage therapeutics include trade ideas that offer returns of  or more  am march    pr newswire  prf sage therapeutics announces inducement grants under nasdaq listing rule c  pm march    businesswire  bzx blog coverage la jollas lead product candidate ljpc posts positive phaseiii trial results  am feb    accesswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pstitch fix has confidentially filed to go public report pcan china make the reflation trade great again pget ready for the lessprofitable amazon that you used to know pmattel stock price target cut to  from  at mkm partners pelectronic arts stock price target raised to  from  at mkm partners pexxon mobil stock price target cut to  from  at cfra pthe states where people spend the most on lotto tickets ptempur sealy stock price target raised to  from  at cfra pfiat chrysler gets approval to sell diesel cars pstarbucks’ teavana stores are the latest casualty at the mall phigh times is going public through a deal with a blankcheck company — and here’s what that means pintel earnings have message for amd and nvidia ‘bring it on’ pfoxconn’s history of broken promises casts a shadow on wisconsin news ptesla’s model  will be launched with panacheand a partylater friday pall the companies in jeff bezos’s empire in one large chart pbaker hughes data show weekly us oilrig count up a third time this month pamazon’s postearnings stock selloff is the smallest in seven years peuropean stocks end at month low as ubs falls tech worries weigh psurging australian dollar makes life tough for central bankers pseptember wti oil trades at bbl little changed from before the rig data loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     sage therapeutics inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports sage therapeutics inc  product pipeline review   sage therapeutics inc  product pipeline review   wgr  august  global  pages global markets direct description table of content sample report enquiry before buy related reports sage therapeutics inc  product pipeline review   summary global markets direct’s ‘sage therapeutics inc  product pipeline review  ’ provides an overview of the sage therapeutics inc’s pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by sage therapeutics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of sage therapeutics inc  the report provides overview of sage therapeutics inc including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses sage therapeutics inc’s pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features sage therapeutics inc’s outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate sage therapeutics inc’s strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for sage therapeutics inc  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding sage therapeutics inc’s pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents table of contents  list of tables  list of figures  sage therapeutics inc snapshot  sage therapeutics inc overview  key information  key facts  sage therapeutics inc  research and development overview  key therapeutic areas  sage therapeutics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  sage therapeutics inc  pipeline products glance  sage therapeutics inc  late stage pipeline products  phase iii productscombination treatment modalities  sage therapeutics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  sage therapeutics inc  early stage pipeline products  indcta filed productscombination treatment modalities  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  sage therapeutics inc  drug profiles  sepranolone  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sage  product description  mechanism of action  rd progress  sge  product description  mechanism of action  rd progress  small molecules to agonize nmda receptor for cognitive disorders  product description  mechanism of action  rd progress  small molecules to agonize nmda receptor for cns disorders  product description  mechanism of action  rd progress  small molecules to modulate gabaa receptor for cns disorders  product description  mechanism of action  rd progress  sage therapeutics inc  pipeline analysis  sage therapeutics inc  pipeline products by target  sage therapeutics inc  pipeline products by route of administration  sage therapeutics inc  pipeline products by molecule type  sage therapeutics inc  pipeline products by mechanism of action  sage therapeutics inc  recent pipeline updates  sage therapeutics inc  dormant projects  sage therapeutics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables sage therapeutics inc key information  sage therapeutics inc key facts  sage therapeutics inc  pipeline by indication   sage therapeutics inc  pipeline by stage of development   sage therapeutics inc  monotherapy products in pipeline   sage therapeutics inc  phase iii   sage therapeutics inc  phase ii   sage therapeutics inc  phase i   sage therapeutics inc  indcta filed   sage therapeutics inc  preclinical   sage therapeutics inc  discovery   sage therapeutics inc  pipeline by target   sage therapeutics inc  pipeline by route of administration   sage therapeutics inc  pipeline by molecule type   sage therapeutics inc  pipeline products by mechanism of action   sage therapeutics inc  recent pipeline updates   sage therapeutics inc  dormant developmental projects  list of figures sage therapeutics inc  pipeline by top  indication   sage therapeutics inc  pipeline by stage of development   sage therapeutics inc  monotherapy products in pipeline   sage therapeutics inc  pipeline by target   sage therapeutics inc  pipeline by route of administration   sage therapeutics inc  pipeline by molecule type   sage therapeutics inc  pipeline products by mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm united states blood bag tube thermosealers market report  in this report the united states blood bag tube thermosealers market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx betwee united states hemodialysis powder solution market report  in this report the united states hemodialysis powder solution market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx betwee united states hemodialyzer market report  in this report the united states hemodialyzer market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  united states intravenous infusion pump market report  in this report the united states intravenous infusion pump market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  global veterinary vaccine market research report  in this report the global veterinary vaccine market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and   purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports united states blood bag tube thermosealers market report  published  july  united states hemodialysis powder solution market report  published  july  united states hemodialyzer market report  published  july  united states intravenous infusion pump market report  published  july  global veterinary vaccine market research report  published  july  × tell a friend about this report your name your email friends name friends email your enquiry send sage therapeutics inc  product pipeline review    the business journals menu select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita limited time offer subscribe now search × close sign in sign in your account your account welcome your account sign in existing users create your free account dont have an account your account subscriptions newsletters custom notifications my custom site manage site users sign out sign in sign in your account search home industries  topics all industries  topics banking  financial services career  workplace commercial real estate education energy food  lifestyle government  regulations health care manufacturing media  marketing philanthropy  nonprofits professional services residential real estate retailing sports business technology transportation travel  tourism sponsored content cre now we value your business office environments small business marketing know your neighborhood news news latest news business pulse press releases lists  awards lists all lists build your own lists people  companies companies top private companies find businesses for sale search for company news people people on the move contact top executives executive profiles search for people in the news events events business event calendar nominations more… jobs find or post a job store subscriptions reprints  more how to grow your business advance your career thought leadership trends tips and insights from our partners subscribers manage your account about  contact about the business journals advertise help  faqs call center directory apps  syndication newsletters acbj publications bizwomen upstart hemmings sports business journal inside lacrosse bostinno dcinno chicagoinno austininno select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita follow us twitter linkedin facebook google  press releases sage therapeutics inc  product pipeline review   sep   pm edt london sept   prnewswire  sage therapeutics inc  product pipeline review  summaryglobal markets directs sage therapeutics inc  product pipeline review   provides an overview of the sage therapeutics incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by sage therapeutics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basisthe report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantagenote certain sections in the report may be removed or altered based on the availability and relevance of datascope the report provides a snapshot of the pipeline therapeutic landscape of sage therapeutics inc the report provides overview of sage therapeutics inc including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses sage therapeutics incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features sage therapeutics incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projectsreasons to buy evaluate sage therapeutics incs strategic position with total access to detailed information on its product pipeline gain strategically significant competitor information analysis and insights to formulate effective rd strategies identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for sage therapeutics inc identify potential new clients or partners in the target demographic plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics devise corrective measures for pipeline projects by understanding sage therapeutics incs pipeline depth and focus of pipeline therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopedownload the full report httpswwwreportbuyercomproductabout reportbuyerreportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttpwwwreportbuyercomfor more information sarah smith research advisor at reportbuyercom email queryreportbuyercom tel      website wwwreportbuyercom to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasessagetherapeuticsincproductpipelinereviewhtml source reportbuyer the information on this page is provided by pr newswire all rights reserved reproduction or redistribution of this content without prior written consent from pr newswire is strictly prohibited is not responsible for this content learn more about this service about pr newswire the information on this page is provided by pr newswire the business journals is not responsible for this content learn more sage therapeutics inc  product pipeline review  homemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets close in  hrs  minssp  dow  nasdaq todays chartsdont get blindsided by teslas shiny new model sage therapeutics inc  product pipeline review  pr newswireseptember  reblogsharetweetsharelondon sept   prnewswire  sage therapeutics inc  product pipeline review   summary global markets directs sage therapeutics inc  product pipeline review   provides an overview of the sage therapeutics incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by sage therapeutics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of sage therapeutics inc  the report provides overview of sage therapeutics inc including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses sage therapeutics incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features sage therapeutics incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate sage therapeutics incs strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for sage therapeutics inc  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding sage therapeutics incs pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope download the full report httpswwwreportbuyercomproduct about reportbuyer reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers httpwwwreportbuyercom for more information sarah smith research advisor at reportbuyercom email queryreportbuyercom tel      website wwwreportbuyercomto view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasessagetherapeuticsincproductpipelinereviewhtmlreblogsharetweetsharerecently viewedyour list is emptywhat to read nexttax cuts just got more likelyyahoo financethis will be in everyones household by banyan hillsponsoredthe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insidertodays charts dont get blindsided by teslas shiny new model yahoo financesbux unicorn frap wasn’t magical enough to save earningsyahoo finance videoengineer finds pattern makes millions in stocksmoney morningsponsoredhow a oneofakind business has kept  kitchens out of landfillsyahoo financethe real reason overseas manufacturing is coming to americayahoo financetrump’s unwitting legacy could be universal health coverageyahoo financezuckerberg wifes ambitious secret finally exposedunewzmesponsored ways to break free from your credit card debtyahoo financehere’s where you can go to see the historic solar eclipseyahoo finance videostocks whiff as earnings and economic data pour inyahoo financediscover it  out of  avg by k customersdiscover cardsponsoredsp lower as amazon tobacco stocks drag dow nasdaq flatreutersthe  most profitable markets for home sellerscreditcomnorth korea fires missile which lands in sea off japanmick palumbo send godzilla to n korea hell know what to dojoin the conversation  k overview  sage therapeutics inc menu investors  media overview overview corporate governance management board of directors committee composition press releases events  presentations sec filings annuals and proxies investor faqs financials  filings quarterly results key ratios stock information historic stock lookup investment calculator analyst coverage email alerts subscription sage therapeutics is a clinicalstage biopharmaceutical company committed to developing and commercializing novel medicines to treat lifethreatening rare central nervous system or cns disorders sages lead program sage is in clinical development for superrefractory status epilepticus srse and is the first of several compounds the company is developing in its portfolio of potential seizure medicines sages proprietary chemistry platform has generated multiple new compounds that target gabaa and nmda receptors which are broadly accepted as impacting many psychiatric and neurological disorders investor inquiries irsagerxcom media inquiries mediasagerxcom nasdaq sage     day high  day low   volume      pm et on jul   delayed  min by esignal intra  mo  mo  yr press releases jul   sage therapeutics to report second quarter  financial results on thursday august   jul   sage therapeutics announces inducement grants under nasdaq listing rule c view all press releases » events  presentations aug   at  pm et sage therapeutics q  financial results conference call view all events  presentations » briefcase briefcase email alerts email alerts downloads downloads snapshot snapshot rss rss print print email email share share facebook google linkedin twitter email rss search search